ORGANICHEM CORP. has begun the construction of a two-story manufacturing building, to be completed late this year, that will house two completely isolated suites for the small-scale manufacture of highly potent active ingredients HPAIs. ... ORGANICHEM CORP. has begun the construction of a two-story...
ALBANY MOLECULAR Research Inc. AMRI is investing in Organichem Corporation, a new contract manufacturing entity formed by the management of Nycomed Amersham PLC. Simultaneously, Organichem has closed its agreement to purchase Nycomed's chemical m ALBANY MOLECULAR Research Inc. AMRI is investing in Organichem ...
By Joshua Hurwit, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News May 12--State leaders on Tuesday announced a revision to the Empire Zone in Rensselaer County that will benefit five existing businesses. The modified zone, approved in February by the...
Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Jan. 14--WAGE INCREASES INCLUDED IN NEW ORGANICHEM CONTRACT: Albany Molecular Research Inc. has reached a new labor agreement with 105 workers employed at its Rensselaer-based subsidiary, Organichem Corp. ...
By Jeremy Boyer, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Mar. 3--RENSSELAER, N.Y.--The future was cloudy at best for the pharmaceutical plant on Riverside Avenue during the late 1990s. The 23-acre facility, then owned by British company Nycomed...
ALBANY MOLECULAR Research Inc. has increased its stake in Organichem Corp. from 39.2 to 75 percent, with plans to acquire the remainder within the next few months. The move completes Albany Molecular's transformation from a drug discovery, research and development company to a "one-stop" shop able...
By Jeremy Boyer, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Jan. 3--Albany Molecular Research Inc. has increased its ownership stake in Organichem Corp., moving a step closer to outright acquisition of the Rensselaer drug manufacturer. Albany...
By Kevin Harlin, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Nov. 19--Drug-discovery firm Albany Molecular Research Inc. showed off $2.2 million in new laboratories at its Corporate Circle headquarters Monday, and said that by the end of next year it...
By Kenneth Aaron, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Aug. 12--Albany Molecular Research Inc. would pay about $30 million to take over Organichem Corp., a Rensselaer drug maker, if it decides to buy the company. ...
RENSSELAER, N.Y.-based Organichem Corp. has acquired the marketing and manufacturing rights to bulk meperidine hydrochloride from SanofiSynthelabo. A schedule II controlled substance and potent synthetic analgesic, meperidine has been continuously manufactured at the Rensselaer site since its discovery there in 1939. ...
Feb. 8--Albany Molecular Research, a rapidly growing and closely watched local firm, has ended the mini-buying spree it began in the fall. The pharmaceutical research company has bought American Advanced Organics, a 2-year-old Syracuse-based maker of drugs to be used in testing,...
Dec. 22--A group of managers at pharmaceutical company Nycomed Amersham have completed what they termed one of the largest management buyouts in Capital Region history by purchasing the drug-making facility from its British parent company for about $60 million. The new company,...
Articles 1999-12-21
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors